Back to search

Article

EFFECT OF THE THIRD DOSE OF ASTRAZENECA VACCINE ON THE ABILITY TO GENERATE ANTI-RBD ANTIBODIES WITHIN TWO AT-RISK POPULATIONS, GERIATRICS AND HEALTH PERSONNEL IN THE PROVINCE OF TUCUMÁN

2022-04-08

Abstract excerpt

This study aims to evaluate the effect on the ability to generate Anti-Anti RBD antibodies (Anti-SAR-CoV 2-Spike-RBD) to the third dose of the AstraZeneca vaccine in two at-risk populations in the Province of Tucumán. Humoral immune responses, assayed by anti-SARS-CoV-2-Spike-RBD IgG ELISA, were measured in 223 participants, including geriatric patients and healthcare workers, at 0, 14 and 28 days after receiving...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2cab9fb-879c-5b35-bea7-daf928dc9518
DOI
10.21203/rs.3.rs-1529527/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EFFECT OF THE THIRD DOSE OF ASTRAZENECA VACCINE ON THE ABILITY TO GENERATE ANTI-RBD ANTIBODIES WITHIN TWO AT-RISK POPULATIONS, GERIATRICS AND HEALTH PERSONNEL IN THE PROVINCE OF TUCUMÁNDOI 10.21203/rs.3.rs-1529527/v1
Effect of the Third Dose of Astrazeneca Vaccine on the Ability to Generate Anti-Rbd Antibodies within Two At-Risk Populations, Geriatrics and Health Personnel in the Province of TucumánSemantic proximity
Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccinationSemantic proximity
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kineticsSemantic proximity
Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19Semantic proximity
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in EnglandSemantic proximity
Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionalsSemantic proximity
Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Elderly People Over 85 Years of Age in GreeceSemantic proximity
SARS-CoV-2 Infection, Vaccination and Antibody Response Trajectories in Adults: A Cohort Study in CataloniaSemantic proximity
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concernSemantic proximity
Antibody Titers After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Immunocompromised Adults in Greece: Necessity of a Fourth DoseSemantic proximity
Immunogenicity and Safety of Gamma, Omicron BA.4/5 and Bivalent SARS-CoV-2 RBD-based Protein Booster Vaccines in Adults Previously Immunized with Different Vaccine Platforms: a Phase II/III, Randomized, Clinical TrialSemantic proximity
The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upSemantic proximity
Select a neighboring publication to make it the new centre.